Home » Topics » Regulatory » Patents

Patents
RSS

Recent Novartis patents describe novel agents for asthma therapy

Feb. 4, 2008

Novel compounds for cancer treatment disclosed in recent patent literature

Feb. 4, 2008

Novel agents for arthritic disorders disclosed in recent patents

Feb. 1, 2008

New anticancer agents disclosed in recent patents

Feb. 1, 2008

New agents for treating neurological disorders described in recent patent literature

Feb. 1, 2008

New treatments for gastrointestinal disorders reported in recent GSK and Anadys patents

Jan. 31, 2008

Recent AstraZeneca and GSK patents describe novel diagnostic agents

Jan. 31, 2008

Novel therapeutic agents for infections disclosed in recent patent literature

Jan. 31, 2008

Recent patents disclose novel neuropsychiatric agents

Jan. 30, 2008

HIF prolyl hydroxylase inhibitors for anemia prepared and tested at GSK

Jan. 30, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.